Airway Clearance Systems Market (2026 - 2033)

Airway Clearance Systems Market Summary

The global airway clearance systems market was valued at USD 665.6 million in 2025 and is projected to grow from USD 699.5 million in 2026 to USD 992.5 million in 2033, at a CAGR of 5.1% from 2026 to 2033. The North America market dominated with the largest revenue share in 2025. The driving factors of the growth are rising chronic respiratory diseases, leading to the rising adoption of airway clearance systems. The rise in chronic respiratory diseases is a major driver of market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Key Market Trends & Insights

• By device type: The flutter mucus clearance devices segment held the largest market share of around 35.0% in 2025.
• By end-use: The home care segment held the largest market share of over 60.0% in 2025.
• By application: The cystic fibrosis segment held the largest market share of over 34.0% in 2025.

Regional Highlights

• Largest regional market: North America (Largest revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)

Market Size & Forecast

• Market size in 2025: USD 665.6 Million
• Estimated market size in 2026: USD 699.5 Million
• Projected market size by 2033: USD 992.5 Million
• CAGR (2026-2033): 5.1%

The emergence of obstructive pulmonary disease affects the airway structure of the lungs, leading to the increased adoption of airway clearance systems and driving the market growth. The rising tobacco consumption and air pollution are attributed to the increasing chronic respiratory diseases. Such conditions aggravate respiratory diseases and are responsible for increasing demand for airway clearance systems in the market. Severe bacterial pneumonia cases led to more complications, such as acute respiratory distress syndrome (ARDS), causing harm to the lungs. According to The Johns Hopkins University, patients suffering from ARDS are unable to breathe and require ventilator support. Such instances are expected to drive the airway clearance systems market growth.

Analyst Perspective

The global airway clearance systems market has been experiencing significant growth. Some of the key factors contributing to the rising demand for these devices include the increasing prevalence of COPD and cystic fibrosis, the growing demand for non-invasive, portable, and easy-to-use devices in home-based care delivery, an inclination toward preventive pulmonary care, and rising comorbidities & neuro-muscular diseases. The advancements in the airway clearance systems, such as portability, light weight, and ease of use, have also complemented the overall shift in the healthcare industry from hospital-based respiratory care to home care settings. Manufacturers focusing on technological innovations, such as the integration of digital systems, wireless connectivity enabling remote patient monitoring, and optimizing therapy outcomes, have further boosted the market growth.

Device Type Insights

Flutter mucus clearance devices dominated the market, accounting for 35.0% of the market in 2025. The factors attributed to the marker growth include the rising cases of chronic lung diseases such as chronic bronchitis and asthma. Rising asthma cases in children and adults are a primary non-communicable disease that causes mucus buildup in the lungs, leading to congestion. Flutter mucus clearance devices are used to treat this condition. Various companies that offer Flutter mucus clearance devices, such as Flexicare (Group) Limited, Sanrai, and Clement Clarke International Limited, are expected to drive the segment growth.

The high frequency chest wall oscillation (HFCWO) segment is expected to grow significantly during the forecast period. The rise in genetic conditions such as cystic fibrosis and bronchiectasis, which build mucus in the lungs and block the airways, is driving the segment growth. HFCWO is a physical therapy for the chest to clear the mucus from the airways and enable breathing. The increased demand due to growing incidences encourages companies to launch new products. For instance, in June 2026, Tactile Medical launched the next-generation AffloVest airway clearance therapy, a HFCWO device-induced therapy with advancements such as reduced weight, size adjustability, and built-in Wi-Fi & Bluetooth, enhancing clinical effectiveness. Such developments are expected to facilitate the segment growth.

End Use Insights

Home care settings accounted for the largest market revenue share, at 60.0%, in 2025. The factors driving the segment growth are majorly attributable to the device’s portability, affordability, user-friendly systems, and the emergency need to enable breathing for patients with congestion. For instance, Clement Clarke’s flutter mucus clearance device is portable, user-friendly, and effective at clearing mucus, enabling patients to breathe without difficulty. Companies are involved in bringing innovative, advanced solutions to market, such as Hill-Rom’s Bluetooth-enabled VisiVest Airway Clearance system and the Monarch airway system, a mobile respiratory solution. Such wide availability in the market drives segment growth.

Ambulatory surgical centers are projected to grow at the fastest CAGR over the forecast period. Ambulatory surgical centers can help patients reduce their risk of infection by reducing antibiotic resistance compared to hospitals. In addition, they are inexpensive and efficient and increase patient satisfaction. In such severe cases, doctors recommend additional therapies such as oxygen therapy and surgical options, such as lung volume reduction surgery, lung transplant, and bullectomy. Such advanced treatment options are owing to the growth of the segment.

Application Insights

Cystic fibrosis dominated the market, accounting for 34.0% of the market share in 2025. The rising prevalence of the genetic condition is driving the segment growth. This genetic condition produces excess mucus that can cause blockages or lung infections, making breathing difficult. Various airway clearance techniques are used to treat cystic fibrosis, such as high-frequency chest wall oscillation (HFCWO), resulting in an increased demand for airway clearance systems, driving segment growth.

The bronchiectasis segment is expected to register the fastest CAGR during the forecast period. The condition damages the airways and cannot clear the mucus, affecting the lung’s immune system and deteriorating with old age. For instance, according to the American Lung Association, between 350,000 and 500,000 adults in the U.S. are affected by bronchiectasis a chronic and progressive lung condition. Various airway removal devices and therapies are used to treat the condition, such as high-frequency chest wall oscillation (HFCWO) therapy and oscillating positive expiratory pressure (OPEP) devices. Companies such as Electromed, Inc. offer solutions, including the SmartVest Airway Clearance System, to treat bronchiectasis. Such innovations are expected to drive the segment growth in the market.

Regional Insights

The North America airway clearance systems market dominated in 2023. The rising prevalence of chronic respiratory disease is driving the market growth. For instance, the COPD Foundation estimates that more than 30.0 million Americans are affected by COPD, comprising emphysema and chronic bronchitis. The Canadian government is taking initiatives and is forming guidelines for chronic respiratory diseases, including asthma and COPD. The government has also initiated the National Lung Health framework, an approach to prevent and manage chronic respiratory diseases and positively impact lung health in the country. Such progressions are expected to drive the region’s airway clearance systems market.

U.S. Airway Clearance Systems Market

The U.S. airway clearance systems market accounted for a significant share of the global market in 2025. The rising prevalence of chronic respiratory diseases such as COPD and cystic fibrosis drives market growth. Such rising in nationwide incidence is increasing demand for airway clearance systems. Companies are working the meet rising demand and expand their airway clearance product portfolios. In January 2025, a medical technology industry participant, Inogen, Inc., with an extensive portfolio of innovative respiratory products, announced a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., which is expected to extend Inogen’s product portfolio through the distribution of multiple products in the U.S. market, while enhancing its innovation pipeline and accelerating Inogen’s entry in the Chinese market.

Europe Airway Clearance Systems Market Trends

Europe accounted for a significant market share in 2025 in the airway clearance systems market. The rising number of patients, companies developing advanced alternatives, and government initiatives drive market growth. Overlooking the rising infectious diseases, the government is taking initiatives to provide better health options. For instance, the European Respiratory Society (ERS) and Lungs Europe have formed an association for a project named EU PAL-COPD, to integrate respiratory medicine across the region. Such initiatives are expected to drive market growth in the region.

The rise in respiratory disease incidences is driving an increase in airway clearance systems in the UK. According to the NHS England, respiratory disease affects one in five people. It is the third most significant cause of death in the country, which includes COPD, lung cancer, and pneumonia. Various institutions and companies are involved in the research and development of advanced solutions to treat respiratory diseases.

Asia Pacific Airway Clearance Systems Market Trends

Asia Pacific airway clearance systems market is estimated to register the fastest CAGR over the forecast period. The rising incidences of chronic respiratory diseases such as COPD are the primary factors for the market growth in the region. Companies are offering a range of airway clearance devices in the nation, such as flutter mucus clearance respiratory device, aerobika device to treat COPD, cystic fibrosis, and bronchiectasis and a positive expiratory pressure exerciser (PEPE) to clear mucus and reduce airway obstruction. Such instances are expected to drive market growth. The rising incidences of chronic respiratory diseases in India are driving market growth in the region.

Key Airway Clearance Systems Company Insights

The airway clearance systems industry features a range of global, regional, and local players, making it a competitive market. The world’s leading companies are using partnerships, collaborations, acquisitions, mergers, and agreements as strategies to withstand the intense competition and increase their market share.

• Baxter develops, manufactures, and markets medical products catered to hospitals, clinics, kidney dialysis centers, and research laboratories. The company offers a wide range of respiratory care products such as monarch airway clearance, volara system, life2000 ventilators, and vest airway clearance system.
• Med Systems, Inc. is an airway clearance device manufacturer that provides respiratory care products. The company has manufactured patented anatomical anesthesia masks and offers a range of respiratory products such as electro flo 5000, fluid flo 2500, fluid flo 2700, and fluid flo 2900.

Key Airway Clearance Systems Companies

The following key companies have been profiled for this study on the airway clearance systems market:

• Baxter

• Electromed, Inc.

• Koninklijke Philips N.V.

• General Physiotherapy II LLC

• AbbVie Inc.

• Med Systems, Inc.

• Smiths Group plc

• JAEGER MEDICAL GMBH

• PARI GmbH

Recent Developments

• In February 2026, Zydus, launched PEPAIR, an affordable oscillating positive expiratory pressure (OPEP) device designed for utilization in the treatment of COPD, asthma, and bronchiectasis.

• In October 2025, Synchrony Medical launched its Airway Clearance System, LibAirty in the U.S. market, with aim to offer advanced at-home therapy to people living with chronic lung disease

• In December 2024, Inogen a medical technology company announced FDA 510(k) clearance for its SIMEOX 200 airway clearance device, a next generation of its original Simeox, used in the treatment of COPD and cystic fibrosis.

Global Airway Clearance Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global airway clearance systems market report based on device, application, end use, and region:

• Device Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Positive Expiratory Pressure (PEP)

  • Flutter Mucus Clearance Device

  • High Frequency Chest Wall Oscillation (HFCWO)

  • Intrapulmonary Percussive Ventilation (IPV)

  • Others

• Application Outlook (Revenue, USD Million, 2021 – 2033)

  • Cystic Fibrosis

  • Neuromuscular

  • Bronchiectasis

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals and Clinics

  • Home care settings

  • Ambulatory Surgical Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

  • Middle East and Africa (MEA)

    • KSA

    • UAE

    • South Africa